Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.50 -0.76 (-6.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Monte Rosa Therapeutics (GLUE) Price to Sales (2024 - 2026)

Updated

Monte Rosa Therapeutics' Price to Sales was 71.80 in Q2 2026, compared with 2.08 a year earlier and up 122.3% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Monte Rosa Therapeutics came in at 10.53, up 86.6% from FY2024.

  • In earlier years, Price to Sales was 5.64 in FY2024.
  • The Q2 2026 figure marks the highest quarterly Price to Sales since Q1 2024.
  • Compared with a year earlier, Price to Sales was higher in 1 of the last four quarters, with an average decline of 49.0%.
  • Per Business Quant data, GLUE's Price to Sales in the three quarters before Q2 2026 was 32.29 (Q1 2026), 10.53 (Q4 2025) and 3.36 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Monte Rosa Therapeutics 894.88 Mn 306.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71.80
Mar 31, 2026 32.29
Dec 31, 2025 10.53
Sep 30, 2025 3.36
Jun 30, 2025 2.08
Mar 31, 2025 2.39
Dec 31, 2024 5.64
Sep 30, 2024 29.03
Jun 30, 2024 39.83
Mar 31, 2024 332.62
API Access

Monte Rosa Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=GLUE&period=max&api_key=YOUR_API_KEY